CAS NO: | 1642579-30-3 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
Cas No. | 1642579-30-3 |
Canonical SMILES | OC(C=C1)=CC=C1C[C@H](NC([C@H](CO)NC([C@@H](NC([C@@H](NC([C@H]2NC(CC2)=O)=O)CC3=CN=CN3)=O)CC4=CNC5=CC=CC=C45)=O)=O)C(N[C@@H](C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N6[C@@H](CCC6)C(NCC)=O)=O)=O)=O)CC7=CNC8=CC=CC=C78)=O.CC(O)=O |
分子式 | C64H83N17O12·XC2H4O2 |
分子量 | 1282.5 |
溶解度 | DMF: 5 mg/ml,DMSO: 5 mg/ml,Ethanol: 10 mg/ml |
储存条件 | -20°C |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
半岛bd体育手机客户端 描述 | Deslorelin is a peptide agonist of gonadotropin-releasing hormone (GnRH).1It binds to the GnRH receptor (GnRHR) with a Kivalue of 0.1 nM. Deslorelin decreases testicular volume, semen volume, sperm motility, and total sperm count, as well as increases the percentage of abnormal sperm, in dogs when administeredviaa subcutaneous implant at doses of 3, 6, and 12 mg/kg.2It decreases disease severity and plasma levels of estradiol, 17-hydroxyprogesterone, and androstenedione in ferrets with adrenocortical disease (ACD) when administered at doses ranging from 3 to 4.41 mg/kg per implant.3Deslorelin (4.7 mg/implant per animal) suppresses ovulation and estrus in cats.4Formulations containing deslorelin have been used in the management of ACD in ferrets and ovulation regulation and artificial insemination in horses. 1.Nederpelt, I., Georgi, V., Schiele, F., et al.Characterization of 12 GnRH peptide agonists - a kinetic perspectiveBr. J. Pharmacol.173(1)128-141(2016) 2.Junaidi, A., Williamson, P.E., Martin, G.B., et al.Dose-response studies for pituitary and testicular function in male dogs treated with the GnRH superagonist, deslorelinReprod. Domest. Anim.44(5)725-734(2009) 3.Wagner, R.A., Pich?, C.A., J?chle, W., et al.Clinical and endocrine responses to treatment with deslorelin acetate implants in ferrets with adrenocortical diseaseAm. J. Vet. Res.66(5)910-914(2005) 4.Ackermann, C.L., Volpato, R., Destro, F.C., et al.Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queensTheriogenology78(4)817-822(2012) |